The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 5093-5101

  Arafat, Mhd Ayman ^a,b   Weickert, Martin O ^a,b   Frystyk, Jan ^c   Spranger, Joachim ^a,b   Schöfl, Christof ^d   Möhlig, Matthias ^a,b   Pfeiffer, Andreas F H ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; NEUTRAL INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

EID: 73249148520     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0875     Document Type: Article

References (39)

1. Sjögren K, Wallenius K, Liu JL, Bohlooly Y, Pacini G, Svensson L, Törnell J, Isaksson OG, Ahrén B, Jansson JO, Ohlsson C 2001 Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50:1539-1545
2. Nakae J, Barr V, Accili D 2000 Differential regulation of gene expression by insulin and IGF-I receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 19:989-996
3. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D 2004 The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 89:114-120
4. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW 1998 Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 18:277-282
5. Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM 2006 Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp Clin Endocrinol Diabetes 114:371-376
6. Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM 2002 Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes. Diabetes 51:2629-2636
7. Johnsen SP, Hundborg HH, Sorensen HT, Orskov H, Tjønneland A, Overvad K, Jørgensen JO 2005 Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 90:5937-5941
8. Brugts MP, van den Beld AW, Hofland LJ, van der Wansem K, van Koetsveld PM, Frystyk J, Lamberts SW, Janssen JA 2008 Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. J Clin Endocrinol Metab 93:2515-2522
9. Maddux BA, Chan A, De Filippis EA, Mandarino LJ, Goldfine ID 2006 IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 29:1535-1537
10. Durham SK, Suwanichkul A, Scheimann AO, Yee D, Jackson JG, Barr FG, Powell DR 1999 FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. Endocrinology 140:3140-3146
11. Wheatcroft SB, Kearney MT, Shah AM, Ezzat VA, Miell JR, Modo M, Williams SC, Cawthorn WP, Medina-Gomez G, Vidal-Puig A, Sethi JK, Crossey PA 2007 IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 56:285-294
12. Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK 2000 Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab 85:4712-4720
13. Frystyk J 2004 Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 14:337-375
14. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H 1999 Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 15:314-322
15. Rasmussen MH, Juul A, Hilsted J 2007 Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism. Obesity (Silver Spring) 15:879-886
16. Rasmussen MH, Juul A, Kjems LL, Hilsted J 2006 Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects. Eur J Endocrinol 155:575-581
17. Ricart W, Fernández-Real JM 2001 No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance. Obes Res 9:631-636
18. Frystyk J, Ritzel RA, Maubach J, Busing M, Luck R, Klempnauer J, Schmiegel W, Nauck MA 2008 Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous vs. systemic-venous graft drainage: impact on glucose regulatory hormones and the GH/IGF-I axis. J Clin Endocrinol Metab 93:1758-1766
19. Scacchi M, Pincelli AI, Cavagnini F 1999 Growth hormone in obesity. Int J Obes Relat Metab Disord 23:260-271
20. Arafat AM, Möhlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Schöfl C, Pfeiffer AF 2008 Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab 93:1254-1262
21. Chen JW, Nielsen MF, Caumo A, Vilstrup H, Christiansen JS, Frystyk J 2006 Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. Eur J Endocrinol 155:285-292
22. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
23. Chen JW, Ledet T, Orskov H, Jessen N, Lund S, Whittaker J, DeMeyts P, Larsen MB, Christiansen JS, Frystyk J 2003 A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 284:E1149-E1155
24. Brugts MP, Ranke MB, Hofland LJ, van der Wansem K, Weber K, Frystyk J, Lamberts SW, Janssen JA 2008 Normal values of circulating IGF-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays. J Clin Endocrinol Metab 93: 2539-2545
25. Chen JW, Højlund K, Beck-Nielsen H, Sandahl CJ, Orskov H, Frystyk J 2005 Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects. J Clin Endocrinol Metab 90:366-371
26. Clemmons DR 2007 Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 6:821-833
27. Rajaram S, Baylink DJ, Mohan S 1997 Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18:801-831
28. Nichols TC, Busby Jr WH, Merricks E, Sipos J, Rowland M, Sitko K, Clemmons DR 2007 Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia. Endocrinology 148:5002-5010
29. Ning Y, Schuller AG, Conover CA, Pintar JE 2008 Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol Endocrinol 22:1213-1225
30. Nyomba BL, Berard L, Murphy LJ 1997 Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab 82:2177-2181
31. Unden AL, Elofsson S, Brismar K 2005 Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study. Clin Endocrinol (Oxf) 63:94-102
32. Holt RI, Simpson HL, Sönksen PH 2003 The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet Med 20:3-15
33. Schneider MR, Lahm H, Wu M, Hoeflich A, Wolf E 2000 Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. FASEB J 14:629-640
34. Bradshaw SL, Han VK 1993 Hormonal regulation of astroglial insulin-like growth factor (IGF)-binding protein gene expression by IGFs and insulin. Endocrinology 133:1767-1777
35. Schmid C, Schlapfer I, Waldvogel M, Meier PJ, Schwander J, Boni-Schnetzler M, Zapf J, Froesch ER 1992 Differential regulation of insulin-like growth factor binding protein (IGFBP)-2 mRNA in liver and bone cells by insulin and retinoic acid in vitro. FEBS Lett 303:205-209
36. Böni-Schnetzler M, Schmid C, Mary JL, Zimmerli B, Meier PJ, Zapf J, Schwander J, Froesch ER 1990 Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes. Mol Endocrinol 4:1320-1326
37. Clemmons DR, Snyder DK, Busby Jr WH 1991 Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab 73:727-733
38. Rizza RA, Mandarino LJ, Gerich JE 1982 Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31(8 Pt 1):663-669
39. Clemmons DR 2004 Role of insulin-like growth factor in maintaining normal glucose homeostasis. Horm Res 62(Suppl 1):77-82